Drugs Made In America Acquisition Corp. Ordinary Shares (NASDAQ: DMAA) is a Financial Services company (Shell Companies) with a market capitalization of $265M. The Maz Rating grades it against the other companies in its sector.
Drugs Made In America Acquisition Corp. Ordinary Shares's current Maz Rating and its five factor grades are for members: log in to see them.
At $10.90, Drugs Made In America Acquisition Corp. Ordinary Shares trades at 61.8x trailing earnings. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of 3.5%, return on invested capital of -1.7% and a free cash flow yield of -0.2%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 0.02. Over the past 52 weeks the share price ranged from $10.15 to $10.91, with a beta of 0.00.
Drugs Made In America Acquisition Corp. Ordinary Shares does not currently pay a dividend.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.